New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2014
07:33 EDTJAZZJazz Pharmaceuticals price target raised to $207 from $171 at Brean Capital
Brean Capital raised its price target on Jazz Pharmaceuticals following Q4 earnings and the EU approval of its Defibrio drug. Shares are Buy rated.
News For JAZZ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 30, 2015
07:24 EDTJAZZStifel to hold a bus tour
BioTrek: 2015 West Coast Healthcare Therapeutics Bus Tour travels throughout San Francisco on March 30-April 1.
March 27, 2015
06:17 EDTJAZZJazz Pharmaceuticals assumed with a Buy at Citigroup
Price target lowered to $195 from $202.
March 26, 2015
07:30 EDTJAZZDeutsche Bank to hold a conference
Pharma One-on-One Day is being held in Denver, Colorado on March 26.
March 18, 2015
13:05 EDTJAZZJazz Pharmaceuticals management to meet with Piper Jaffray
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use